LeadIQ logo
Learn more at LeadIQ.com

Insights

Loading spinner
Gathering insights about NeuroSense Therapeutics…

Similar companies to NeuroSense Therapeutics

NeuroSense Therapeutics Tech Stack

NeuroSense Therapeutics uses 8 technology products and services including Open Graph, oEmbed, RequireJS, and more. Explore NeuroSense Therapeutics's tech stack below.

  • Open Graph
    Content Management System
  • oEmbed
    Dev Tools
  • RequireJS
    Javascript Frameworks
  • React
    Javascript Frameworks
  • Elementor
    Page Builders
  • Google Tag Manager
    Tag Management
  • Nginx
    Web Servers
  • jQuery Waypoints
    Web Tools And Plugins

Media & News

NeuroSense Therapeutics's Email Address Formats

NeuroSense Therapeutics uses at least 1 format(s):
NeuroSense Therapeutics Email FormatsExamplePercentage
First@neurosense-tx.comJohn@neurosense-tx.com
50%
First@neurosense-tx.comJohn@neurosense-tx.com
50%

Frequently Asked Questions

Where is NeuroSense Therapeutics's headquarters located?

Minus sign iconPlus sign iconNeuroSense Therapeutics's main headquarters is located at 1 Broadway, Cambridge, Massachusetts 02142, US. The company has employees across 3 continents, including AsiaNorth AmericaEurope.

What is NeuroSense Therapeutics's official website and social media links?

Minus sign iconPlus sign iconNeuroSense Therapeutics's official website is neurosense-tx.com and has social profiles on LinkedInCrunchbase.

What is NeuroSense Therapeutics's SIC code NAICS code?

Minus sign iconPlus sign iconNeuroSense Therapeutics's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does NeuroSense Therapeutics have currently?

Minus sign iconPlus sign iconAs of October 2025, NeuroSense Therapeutics has approximately 32 employees across 3 continents, including AsiaNorth AmericaEurope. Key team members include Chief Medical Officer: F. T.Chief Financial Officer: O. E.Chief Technology Officer: N. R. B.. Explore NeuroSense Therapeutics's employee directory with LeadIQ.

What industry does NeuroSense Therapeutics belong to?

Minus sign iconPlus sign iconNeuroSense Therapeutics operates in the Biotechnology Research industry.

What technology does NeuroSense Therapeutics use?

Minus sign iconPlus sign iconNeuroSense Therapeutics's tech stack includes Open GraphoEmbedRequireJSReactElementorGoogle Tag ManagerNginxjQuery Waypoints.

What is NeuroSense Therapeutics's email format?

Minus sign iconPlus sign iconNeuroSense Therapeutics's email format typically follows the pattern of First@neurosense-tx.com. Find more NeuroSense Therapeutics email formats with LeadIQ.

How much funding has NeuroSense Therapeutics raised to date?

Minus sign iconPlus sign icon As of October 2025, NeuroSense Therapeutics has raised $5M in funding. The last funding round occurred on Dec 02, 2024 for $5M.

When was NeuroSense Therapeutics founded?

Minus sign iconPlus sign iconNeuroSense Therapeutics was founded in 2017.
NeuroSense Therapeutics

NeuroSense Therapeutics

Biotechnology ResearchUnited States11-50 Employees

Advancing research, development and therapy for ALS and additional CNS indications.

NeuroSense Therapeutics Ltd. (NASDAQ: NRSN) is a clinical stage Biotech company focusing on the development of a ground-breaking treatment for ALS patients, as well as other neurodegenerative diseases.

Currently in conducting a Phase 2b, double-blind, randomized, placebo controlled clinical study in ALS patients globally.
$NRSN

Section iconCompany Overview

Headquarters
1 Broadway, Cambridge, Massachusetts 02142, US
Website
neurosense-tx.com
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2017
Employees
11-50

Section iconMedia & News

Section iconFunding & Financials

  • $5M

    NeuroSense Therapeutics has raised a total of $5M of funding over 5 rounds. Their latest funding round was raised on Dec 02, 2024 in the amount of $5M.

  • $10M$25M

    NeuroSense Therapeutics's revenue is estimated to be in the range of $10M$25M

Section iconFunding & Financials

  • $5M

    NeuroSense Therapeutics has raised a total of $5M of funding over 5 rounds. Their latest funding round was raised on Dec 02, 2024 in the amount of $5M.

  • $10M$25M

    NeuroSense Therapeutics's revenue is estimated to be in the range of $10M$25M

Company Leadership

  • Stylized image of a person
    F. T.
    Chief Medical Officer
    Phone icon
    Mobile Phone
  • Stylized image of a person
    O. E.
    Chief Financial Officer
    Phone icon
    Mobile Phone
  • Stylized image of a person
    N. R. B.
    Chief Technology Officer
    Phone icon
    Mobile Phone
  • Stylized image of a person
    O. Y. -. Z.
    Chief Scientific Officer, Director Of The Board
    Phone icon
    Mobile Phone
  • Stylized image of a person
    K. P.
    Head Of Hr
    Phone icon
    Mobile Phone

Employee Directory

  • Stylized image of a person
    O. Y. -. Z.
    Chief Scientific Officer, Director Of The Board
    Phone icon
    Mobile Phone
  • Stylized image of a person
    A. G.
    Co-Founder & Investor
    Phone icon
    Mobile Phone
  • Stylized image of a person
    S. C.
    Vp Cmc
    Phone icon
    Mobile Phone
  • Stylized image of a person
    Y. B.
    Vp Qa And Compliance
    Phone icon
    Mobile Phone
  • Stylized image of a person
    K. P.
    Head Of Hr
    Phone icon
    Mobile Phone

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.